MX368918B - Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos. - Google Patents
Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos.Info
- Publication number
- MX368918B MX368918B MX2016010918A MX2016010918A MX368918B MX 368918 B MX368918 B MX 368918B MX 2016010918 A MX2016010918 A MX 2016010918A MX 2016010918 A MX2016010918 A MX 2016010918A MX 368918 B MX368918 B MX 368918B
- Authority
- MX
- Mexico
- Prior art keywords
- magnesium oxide
- applications
- food additive
- oxide granules
- pharmaceutical
- Prior art date
Links
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 title abstract 6
- 239000000395 magnesium oxide Substances 0.000 title abstract 6
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 title abstract 6
- 239000008187 granular material Substances 0.000 title abstract 4
- 239000002778 food additive Substances 0.000 title abstract 3
- 235000013373 food additive Nutrition 0.000 title abstract 3
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 229910001385 heavy metal Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/22—Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F5/00—Compounds of magnesium
- C01F5/02—Magnesia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/12—Surface area
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/80—Compositional purity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Geology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Abstract
Un objetivo de la presente invención es el proveer óxido de magnesio que puede ser usado preferiblemente para aplicaciones farmacéuticas o como un aditivo para alimentos. En particular, el objetivo es proveer gránulos de óxido de magnesio con los cuales se pueden reducir los problemas en el pastillado, así como también se pueden reducir los defectos de calidad, y más particularmente, proveer gránulos de óxido de magnesio con los cuales los problemas de fabricación de tabletas y los defectos de calidad pueden ser reducidos y los cuales tienen una menor incorporación de metales pesados y una alta pureza del óxido de magnesio. Se proveen gránulos de óxido de magnesio para aplicaciones farmacéuticas o para la adición a alimentos que tienen un área de superficie específica BET de 7 a 50 m2/g y CAA80/CAA40 de 2 a 7.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2014/054516 WO2015128940A1 (ja) | 2014-02-25 | 2014-02-25 | 医薬用又は食品添加用酸化マグネシウム顆粒 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2016010918A MX2016010918A (es) | 2016-11-14 |
MX368918B true MX368918B (es) | 2019-10-21 |
Family
ID=54008312
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016010918A MX368918B (es) | 2014-02-25 | 2014-02-25 | Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US10004763B2 (es) |
EP (1) | EP3111957B1 (es) |
JP (1) | JP6343338B2 (es) |
CN (1) | CN106029103B (es) |
CA (1) | CA2938003C (es) |
MX (1) | MX368918B (es) |
WO (1) | WO2015128940A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018030225A1 (ja) * | 2016-08-09 | 2018-02-15 | 神島化学工業株式会社 | 酸化マグネシウム顆粒 |
CN107927883A (zh) * | 2018-01-05 | 2018-04-20 | 长沙兴嘉生物工程股份有限公司 | 一种微量营养素补充剂颗粒的制备方法及制备装置 |
FR3092993B1 (fr) * | 2019-02-21 | 2021-05-21 | Timab Magnesium | Supplément à base de magnésium pour volailles |
US11865139B2 (en) * | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
CN116143150A (zh) * | 2021-09-01 | 2023-05-23 | 河北镁神科技有限公司 | 一种压片用食品级颗粒氧化镁及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4443425A (en) * | 1981-12-09 | 1984-04-17 | Calgon Corporation | Magnesium oxide composition for coating silicon steel |
JP2665451B2 (ja) | 1993-12-28 | 1997-10-22 | タテホ化学工業株式会社 | アルカリ土類金属酸化物の製造方法 |
JP4192282B2 (ja) | 1997-12-01 | 2008-12-10 | Jfeスチール株式会社 | 焼鈍分離剤用MgOの製造方法 |
JP4192283B2 (ja) | 1997-12-24 | 2008-12-10 | Jfeスチール株式会社 | 方向性電磁鋼板の製造方法 |
JP2001048792A (ja) | 1998-11-26 | 2001-02-20 | Fujix Kk | 瀉下剤 |
JP3939102B2 (ja) | 2001-03-05 | 2007-07-04 | 宇部マテリアルズ株式会社 | 低Pb酸化マグネシウムからなる食品添加剤 |
JP2003033159A (ja) * | 2001-07-24 | 2003-02-04 | Kyowa Hakko Kogyo Co Ltd | 食品添加用酸化マグネシウム粉末 |
JP4015485B2 (ja) | 2001-08-27 | 2007-11-28 | 協和化学工業株式会社 | 制酸・緩下用錠剤 |
KR20090065552A (ko) | 2001-08-27 | 2009-06-22 | 교와 가가꾸고교 가부시키가이샤 | 제산 ·완하용 정제 |
JP4833567B2 (ja) | 2005-03-14 | 2011-12-07 | 協和発酵バイオ株式会社 | 酸化マグネシウム粒子 |
JP5160156B2 (ja) | 2007-07-05 | 2013-03-13 | 株式会社オオツカ | 栄養機能食品錠剤 |
JP4714929B2 (ja) | 2008-02-29 | 2011-07-06 | 富田製薬株式会社 | 酸に不安定な薬剤用安定化剤 |
SG10201401678TA (en) * | 2009-04-22 | 2014-06-27 | Kyowa Chem Ind Co Ltd | Tablet and pestle therefor |
AU2010293637B2 (en) | 2009-09-08 | 2015-12-03 | Kyowa Chemical Industry Co., Ltd. | Antacid and laxative tablet |
JP5415215B2 (ja) | 2009-10-02 | 2014-02-12 | タテホ化学工業株式会社 | 分散性に優れる酸化マグネシウム粉末及びその製造方法 |
CN102515576B (zh) * | 2011-12-05 | 2016-03-30 | 韩大庆 | 磷酸镁水泥用氧化镁及其制备方法和磷酸镁水泥 |
-
2014
- 2014-02-25 CN CN201480075960.2A patent/CN106029103B/zh active Active
- 2014-02-25 EP EP14883684.4A patent/EP3111957B1/en active Active
- 2014-02-25 MX MX2016010918A patent/MX368918B/es active IP Right Grant
- 2014-02-25 JP JP2016504889A patent/JP6343338B2/ja active Active
- 2014-02-25 WO PCT/JP2014/054516 patent/WO2015128940A1/ja active Application Filing
- 2014-02-25 CA CA2938003A patent/CA2938003C/en active Active
- 2014-02-25 US US15/118,950 patent/US10004763B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3111957A4 (en) | 2017-10-25 |
JP6343338B2 (ja) | 2018-06-13 |
CN106029103B (zh) | 2021-12-31 |
US10004763B2 (en) | 2018-06-26 |
EP3111957B1 (en) | 2018-11-21 |
MX2016010918A (es) | 2016-11-14 |
JPWO2015128940A1 (ja) | 2017-03-30 |
EP3111957A1 (en) | 2017-01-04 |
US20170042935A1 (en) | 2017-02-16 |
WO2015128940A1 (ja) | 2015-09-03 |
CA2938003A1 (en) | 2015-09-03 |
CA2938003C (en) | 2019-01-08 |
CN106029103A (zh) | 2016-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021003230A (es) | Composiciones farmaceuticas que comprenden meloxicam. | |
EP3113800A4 (en) | Enhanced production of recombinant crm197 in e. coli | |
EP3225619A4 (en) | 2-aminopyrimidine compound and pharmaceutical composition and use thereof | |
EP3233111A4 (en) | Pharmaceutical composition comprising plasminogen and uses thereof | |
EP3513283A4 (en) | PROCESSING OF CONTENT IN APPLICATIONS | |
MX368918B (es) | Granulos de oxido de magnesio para aplicaciones farmaceuticas o para uso como aditivos de alimentos. | |
WO2015191945A3 (en) | Solid state forms of sofosbuvir | |
EP3133152A4 (en) | Novel bacteriophage, and composition containing same | |
EP3491551A4 (en) | GEOMETRY-BASED, SPACE-CONSCIOUS SHELF / WRITEGROUP EVACUATION | |
EP3123287A4 (en) | Alternate dynamic keyboard for convertible tablet computers | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
EP3305673A4 (en) | Double container | |
EP3267987A4 (en) | CHEMICALLY MODIFIED CLUROMES FOR USE IN THE PREPARATION OF LIPOXINES | |
EP3135293A4 (en) | Agent for preventing or ameliorating diabetes | |
PL3645016T3 (pl) | Połączenie zawierające tlen i kwas hialuronowy do stosowania miejscowego-dopochwowego | |
EP3297440A4 (en) | COMPOSITION WITH CARBOPLATIN AND USE | |
EP3331504A4 (en) | TABLET COMPOSITION FOR ANTIBIOTICS AGAINST TUBERCULOSIS | |
IN2014MU00916A (es) | ||
EP3602343B8 (en) | Media content tracking | |
EP3197438A4 (en) | Pharmaceutical composition having improved content uniformity | |
WO2016020408A3 (en) | Compounds for preventing ototoxicity | |
EP3114130A4 (en) | Pyridyldiamido transition metal complexes, production and use thereof | |
WO2015101670A3 (en) | Inhibitors of 17beta-hydroxysteroid dehydrogenases type 1 and type 2 | |
GB201411581D0 (en) | Compounds inhibiting the enzyme monopolar spindle 1 kinase, pharmaceutical compositions and uses thereof | |
AU2018297022A1 (en) | Table top |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |